JP Morgan Private Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $204K | Sell |
|
|||||
|
2023
Q1 | $255K | Sell |
|
|||||
|
2022
Q4 | $242K | Sell |
|
|||||
|
2022
Q3 | $325K | Buy |
|
|||||
|
2022
Q2 | $317K | Sell |
|
|||||
|
2022
Q1 | $416K | Sell |
|
|||||
|
2021
Q4 | $770K | Sell |
|
|||||
|
2021
Q3 | $744K | Sell |
|
|||||
|
2021
Q2 | $705K | Sell |
|
|||||
|
2021
Q1 | $836K | Sell |
|
|||||
|
2020
Q4 | $652K | Sell |
|
|||||
|
2020
Q3 | $655K | Sell |
|
|||||
|
2020
Q2 | $797K | Buy |
|
|||||
|
2020
Q1 | $513K | Buy |
|
|||||
|
2019
Q4 | $581K | Sell |
|
|||||
|
2019
Q3 | $563K | Buy |
|
|||||
|
2019
Q2 | $409K | Sell |
|
|||||
|
2019
Q1 | $457K | Buy |
|
|||||
|
2018
Q4 | $437K | Buy |
|
|||||
|
2018
Q3 | $879K | Sell |
|
|||||
|
2018
Q2 | $1.26M | Buy |
|
|||||
|
2018
Q1 | $963K | Buy |
|
|||||
|
2017
Q4 | $788K | Sell |
|
|||||
|
2017
Q3 | $789K | Buy |
|
|||||
|
2017
Q2 | $646K | Buy |
|
|||||
|
2017
Q1 | $527K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $226K | Sell |
|
|||||
|
2016
Q1 | $404K | Buy |
|
|||||
|
2015
Q4 | $233K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $243K | Buy |
|